Our vision is a world where every person everywhere benefits from timely access to safe, effective, and quality-assured medicines and other health products, including innovative products and emerging technologies, to attain the highest possible level of health and wellbeing. Our mission is to facilitate access to safe, effective and quality assured medicines and health products to achieve universal health coverage goals through the provision of evidence-based normative guidance, standards, specifications, policy and technical assistance to Member States. The scope of our work covers assistive technology; biologicals and biological products (including cell and gene therapies); blood products; internationally controlled medicines and substances; medical devices, including in vitro diagnostics; medicines; and organs, tissues and cell transplantation.
Featured
Events
All →Expert Committees
Advisory groups
Databases
Publications
All →The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use...
The 25th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 5 to 9 May 2025. The Committee...
Blended learning platform for primary health care and community level workers: user guide to Learning...
Learning on TAP (TAP for short) is a blended learning resource developed by WHO and is part of the WHO Academy: https://whoacademy.org/TAP/. TAP is an...
WHO Drug Information - Volume 39, No. 4
The Fourth issue of volume 39 for 2025 includes:Pharmaceutical News- Thin-Layer Chromatography: A Valuable Tool in the Fight Against Substandard/Falsified...
Assistive technology progress assessment questionnaire: tracking progress on access to assistive technology
In May 2018, the World Health Assembly (WHA) adopted resolution WHA71.8 on improving access to assistive technology. The resolution urges Member States...
Journal articles